The purpose of this project is to determine whether changing the location of several glycosyl transferases within the Golgi alters the amount and types of oligosaccharides they make. SLeX and LeX occur on polylactosamine repeats of O-linked sugar chains. Core 2 GicNActransferase is required to initiate their synthesis, and this enzyme is thought to reside in the """"""""mid- Golgi"""""""". An alpha2,6 sialyl transferase that makes sialyl Tn antigen by adding Sia to the Ga1NAc initiating O-linked chains is thought to occur in an """"""""earlier"""""""" Golgi compartment. Addition of this residue blocks Core 2 GlcNAc transferase. A second alpha2,6sialyl transferase terminates extended polylactosamine chains and should be located in the """"""""late Golgi"""""""". Since the putative targeting domains of all Golgi enzymes are thought to lie in the cytoplasmic, transmembrane and stem regions, the catalytic domain can be shuffled to different locations by using different targeting domains. The effects on glycosylation will be monitored by measuring the amount of polylactosamine and sialylated produced made in the different constructs. However, traditional methods to localize the transferases (e.g., immunolocalization) give a low resolution picture of the Golgi and cannot define functionally active glycosyl transferases. We propose to use two related biochemical methods in mapping functionally active glycosyl transferases as they move around the Golgi. Both methods rely on the ability of Golgi to transport and concentrate radiolabeled sugar nucleotides to glycosylate exogenous added synthetic and/or endogenous acceptors. First, synthetic glycoside acceptors (e.g., GaINAcalpha-MU) that prime complex glycan synthesis in living cells will be added to Golgi preparations along with limited amounts of radiolabeled sugar nucleotides (e.g., UDP-[3H]Gal). The acceptors enter all compartments, but are labeled only in those compartments that have glycosyl transferases. and the transport the donors (e.g. O-linked core specific betaGal transferase I, forming GalbetaGalNAcalphaMU). Additional glycosylations (e.g., Core 2 GlcNAc residues) can occur on the same labeled acceptor only if the next transferase is to-localized in that same functional compartment. Second, the same transported donors can also label endogenous products. However, within the compartment where the glycosides were made the amount of transported sugar nucleotide is now limited; there is less to glycosylate the trace amounts of endogenous products awaiting 3H-Gal addition (e.g., N- linked oligosaccharides). As the amount of glycoside product increases, glycosylation of the endogenous acceptors decreases in proportional to the degree of enzyme co-localization. Detailed structural analysis of products made on both added acceptors and endogenous acceptors indicates which transferases are co-localized with each other. This method sketches a detailed map of neighboring functional transferases of several glycosylation pathways within a compartment, and it should reveal change in transferase localization. Results obtained by these methods will be compared to those obtained by traditional immunological techniques to yield an enhanced picture of enzyme localization.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA071932-03
Application #
6269778
Study Section
Project Start
1998-06-24
Project End
1999-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Nonaka, Motohiro; Fukuda, Michiko N; Gao, Chao et al. (2014) Determination of carbohydrate structure recognized by prostate-specific F77 monoclonal antibody through expression analysis of glycosyltransferase genes. J Biol Chem 289:16478-86
Nonaka, Motohiro; Bao, Xingfeng; Matsumura, Fumiko et al. (2014) Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites. Proc Natl Acad Sci U S A 111:8173-8
Sugihara, Kazuhiro; Shibata, Toshiaki K; Takata, Kayoko et al. (2013) Attenuation of fibroblast growth factor signaling by poly-N-acetyllactosamine type glycans. FEBS Lett 587:3195-201
Lee, Seung Ho; Fukuda, Minoru (2013) Study of the biological functions of mucin type core 3 O-glycans. Methods Mol Biol 1022:41-50
Tsuboi, Koichiro; Hirakawa, Jotaro; Seki, Emiko et al. (2013) Role of high endothelial venule-expressed heparan sulfate in chemokine presentation and lymphocyte homing. J Immunol 191:448-55
Suzuki-Anekoji, Misa; Suzuki, Atsushi; Wu, Sz-Wei et al. (2013) In vivo regulation of steroid hormones by the Chst10 sulfotransferase in mouse. J Biol Chem 288:5007-16
Okamoto, Teppei; Yoneyama, Mihoko Sutoh; Hatakeyama, Shingo et al. (2013) Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity. Mol Med Rep 7:359-64
Pols, Maaike S; van Meel, Eline; Oorschot, Viola et al. (2013) hVps41 and VAMP7 function in direct TGN to late endosome transport of lysosomal membrane proteins. Nat Commun 4:1361
Ito, Yuki; Vela, Jose Luis; Matsumura, Fumiko et al. (2013) Helicobacter pylori cholesteryl ?-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One 8:e78191
Hatakeyama, Shingo; Shibata, Toshiaki K; Tobisawa, Yuki et al. (2013) Tumor targeting by a carbohydrate ligand-mimicking peptide. Methods Mol Biol 1022:369-86

Showing the most recent 10 out of 161 publications